Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTR MINERALS LTD AGM Information 2025

Oct 2, 2025

65621_rns_2025-10-02_5d10f36f-8971-444d-8ca3-744925a6c2e5.pdf

AGM Information

Open in viewer

Opens in your device viewer

PETRATHERM LIMITED ACN 106 806 884

NOTICE OF ANNUAL GENERAL MEETING EXPLANATORY MEMORANDUM

PROXY FORM

Date of Meeting Thursday 6 November 2025

Time of Meeting 11:30 am (Adelaide time)

Place of Meeting HLB Mann Judd Level 1 169 Fullarton Road DULWICH SA 5065

NOTICE OF ANNUAL GENERAL MEETING

PETRATHERM LIMITED ACN 106 806 884

Notice is hereby given that the Annual General Meeting of shareholders of Petratherm Limited ( Company ) will be held at HLB Mann Judd, Level 1, 169 Fullarton Road, Dulwich, South Australia at 11:30 am (Adelaide time) on Thursday 6 November 2025.

Ordinary Business

To consider the Financial Statements for the financial year ended 30 June 2025 and accompanying reports of the Directors and Auditor.

Resolution 1: Adoption of Remuneration Report

To consider and, if thought fit, pass, with or without amendment, the following resolution as an ordinary resolution:

' That the Company adopt the Remuneration Report for the year ended 30 June 2025 as set out in the Company ' s Annual Report for the year ended 30 June 2025. '

Resolution 2: Re-election of Donald Stephens as Director

To consider and, if thought fit, pass, with or without amendment, the following resolution as an ordinary resolution:

' That Mr Donald Stephens, having voluntarily retired in accordance with rule 6.1 of the Constitution and being eligible, and offering himself, for re-election, is re-elected as a Director with effect immediately following the conclusion of the Meeting. '

Resolution 3: Election of Robert Sennitt as Director

To consider and, if thought fit, pass, with or without amendment, the following resolution as an ordinary resolution:

' That Mr Robert Sennitt, being a Director who was appointed since the last annual general meeting of the Company, retires pursuant to rule 9.2 of the Constitution and being eligible, and offering himself, for re-election, is re-elected as a Director with effect immediately following the conclusion of the Meeting. '

Resolution 4: Approval to Change Company Name

To consider and, if thought fit, pass, with or without amendment, the following resolution as a special resolution :

'That for the purposes of sections 157 (1) and 136 (2) of the Corporations Act 2001 (Cth) and for all other purposes, the name of the Company be changed from Petratherm Limited to PTR Minerals Limited, and that all references to “Petratherm Limited” in the Constitution of the Company be replaced with references to “PTR Minerals Limited”.’

Page 1

Resolution 5: Approval of 10% Placement Facility

To consider and, if thought fit, pass, with or without amendment, the following resolution as a special resolution :

' That pursuant to and in accordance with ASX Listing Rule 7.1A and for all other purposes, shareholders approve the issue of Equity Securities up to 10% of the issued capital of the Company (at the time of the issue) calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 and on the terms and conditions in the Explanatory Memorandum which is attached to and forms part of this Notice. '

Resolution 6 – Increase in total aggregate remuneration for Non-Executive Directors

To consider and, if thought fit, pass, with or without amendment, the following resolution as an ordinary resolution

‘That, for the purposes of clause 43.1 of the Constitution, Listing Rule 10.17 and for all other purposes, Shareholders approve an increase of the total aggregate amount of fees payable to nonexecutive Directors from $300,000 per annum to $500,000 per annum in accordance with the terms and conditions set out in the Explanatory Statement.’

DATED 3 OCTOBER 2025

BY ORDER OF THE BOARD PETRATHERM LIMITED

==> picture [131 x 46] intentionally omitted <==

KATELYN ADAMS COMPANY SECRETARY

Page 2

NOTES:

1. Explanatory Memorandum

The Explanatory Memorandum accompanying this Notice of Annual General Meeting is incorporated in and comprises part of this Notice of Annual General Meeting and should be read in conjunction with this Notice of Annual General Meeting.

Shareholders are specifically referred to the Glossary in the Explanatory Memorandum which contains definitions of capitalised terms used in both this Notice of Annual General Meeting and the Explanatory Memorandum.

2. Voting Exclusion Statements

2.1 Resolution 1

A vote on Resolution 1 must not be cast (in any capacity) by or on behalf of any of the following persons:

  • (a) a member of the Key Management Personnel details of whose remuneration are included in the Remuneration Report; or

  • (b) a Closely Related Party of such a member.

However, a person described above may cast a vote on Resolution 1 as a proxy if the vote is not cast on behalf of a person described above and either:

  • (a) the person is appointed as a proxy by writing that specifies the way the proxy is to vote on the resolution; or

  • (b) the person is the chair of the meeting and the appointment of the chair as proxy:

  • (1) does not specify the way the proxy is to vote on the resolution; and

  • (2) expressly authorises the chair to exercise the proxy even if the resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company or, if the Company is part of a consolidated entity, for the entity.

2.2 Resolution 6

The Company will disregard any votes cast in favour of Resolution 6 by or on behalf of Directors of the Company, and associates of those persons.

However, this does not apply to a vote cast in favour of Resolution 6 by:

  • a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions given to the proxy or attorney to vote on the resolution in that way; or

  • the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction given to the chair to vote on the resolution as the chair decides; or

Page 3

  • a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the resolution; and

  • the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

  • For the purposes of the Corporations Act, a person appointed as a proxy must not vote, on the basis of that appointment, on Resolution 6 if:

    • the person is either:

      • a member of the Key Management Personnel for the Company or, if the Company is part of a consolidated entity, for the entity; or

      • a Closely Related Party of such a member; and

    • the appointment does not specify the way the proxy is to vote on the Resolution.

However, the Company will not disregard a vote if:

  • the person is the chair of the meeting at which the Resolution is voted on; and

  • the appointment expressly authorises the chair to exercise the proxy even if the Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company or, if the Company is part of a consolidated entity, for the entity.

3. Proxies

A shareholder entitled to attend this Meeting and vote is entitled to appoint a proxy to attend and vote for the shareholder at the Meeting. A proxy need not be a shareholder. If the shareholder is entitled to cast two or more votes at the Meeting the shareholder may appoint two proxies and may specify the proportion or number of votes which each proxy is appointed to exercise. A form of proxy accompanies this Notice.

To record a valid vote, a shareholder will need to take the following steps:

  • 3.1 cast the shareholder's vote online by visiting www.investorvote.com.au and entering the shareholder's Control Number and SRN/HIN, which are shown on the first page of the enclosed proxy form; or

  • 3.2 complete and lodge the manual proxy form at the share registry of the Company, Computershare Investor Services Pty Limited:

  • (a) by post at the following address:

Computershare Investor Services Pty Limited

Page 4

GPO Box 242 MELBOURNE VIC 3001

OR

  • (b) by facsimile on 1800 783 447 (within Australia) or +61 3 9473 2555 (outside Australia); or

  • 3.3 for Intermediary Online subscribers only (custodians), cast the shareholder's vote online by visiting www.intermediaryonline.com,

so that it is received no later than 11:30 am (Adelaide time) on Tuesday 4 November 2025.

Please note that if the chair of the meeting is your proxy (or becomes your proxy by default), you expressly authorise the chair to exercise your proxy on Resolutions 1 and 6 even though they are connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company, which includes the chair. If you appoint the chair as your proxy you can direct the chair to vote for or against or abstain from voting on Resolutions 1 and 6 by marking the appropriate box on the proxy form.

The chair intends to vote undirected proxies in favour of each item of business. In exceptional circumstances, the chair may change his or her voting intention on any resolution, in which case an ASX announcement will be made.

4. 'Snap Shot' Time

The Company may specify a time, not more than 48 hours before the Meeting, at which a 'snap shot' of shareholders will be taken for the purposes of determining shareholder entitlements to vote at the Meeting. The Directors have determined that all shares of the Company that are quoted on ASX as at 7.00 pm (Sydney time) on Tuesday 4 November 2025 shall, for the purposes of determining voting entitlements at the Meeting, be taken to be held by the persons registered as holding the shares at that time.

5. Corporate Representative

Any corporate shareholder who has appointed a person to act as its corporate representative at the Meeting should provide that person with a certificate or letter executed in accordance with the Corporations Act authorising him or her to act as that company's representative. The authority may be sent to the Company and/or registry in advance of the Meeting.

Page 5

EXPLANATORY MEMORANDUM

This Explanatory Memorandum forms part of the Notice convening the Annual General Meeting of shareholders of Petratherm Limited to be held on Thursday 6 November 2025. This Explanatory Memorandum is to assist shareholders in understanding the background to and the legal and other implications of the Notice and the reasons for the resolution proposed. Both documents should be read in their entirety and in conjunction with each other.

Other than the information set out in this Explanatory Memorandum, the Directors believe that there is no other information that could reasonably be required by shareholders to consider Resolutions 1 to 6.

1. RESOLUTION 1: ADOPTION OF REMUNERATION REPORT

The Annual Report for the year ended 30 June 2025 contains a Remuneration Report which sets out the remuneration policy of the Company.

An electronic copy of the 2025 Annual Report is available to download or view on the Company's website at https://www.petratherm.com.au/company-reports/. The 2025 Annual Report has also been sent by post to those shareholders who have previously elected to receive a hard copy.

Section 250R(2) of the Corporations Act requires that a resolution to adopt the Remuneration Report be put to the vote of the Company. Shareholders should note that the vote on Resolution 1 is advisory only and, subject to the matters outlined below, will not bind the Company or the Directors. However, the Board will take the outcome of the vote into consideration when reviewing the Company's remuneration policy.

Section 250R(4) of the Corporations Act prohibits a vote on this resolution being cast (in any capacity) by or on behalf of any of the following persons:

  • (a) a member of the Key Management Personnel details of whose remuneration are included in the Remuneration Report; or

  • (b) a Closely Related Party of such a member.

However, under section 250R(5) of the Corporations Act a person described above may cast a vote on Resolution 1 as a proxy if the vote is not cast on behalf of a person described above and either:

  • (a) the person is appointed as a proxy by writing that specifies the way the proxy is to vote on the resolution; or

  • (b) the person is the chair of the meeting and the appointment of the chair as proxy:

  • (1) does not specify the way the proxy is to vote on the resolution; and

  • (2) expressly authorises the chair to exercise the proxy even if the resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company or, if the Company is part of a consolidated entity, for the entity.

Please note that if the chair of the meeting is your proxy (or becomes your proxy by default), you expressly authorise the chair to exercise your proxy on Resolution 1 even though it is

Page 6

connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company, which includes the chair. If you appoint the chair as your proxy you can direct the chair to vote for or against or abstain from voting on Resolution 1 by marking the appropriate box on the proxy form.

The chair intends to vote undirected proxies in favour of Resolution 1.

Resolution 1 is an ordinary resolution.

Please also note that under sections 250U and 250V of the Corporations Act, if at two consecutive annual general meetings of a listed company at least 25% of votes cast on a resolution that the remuneration report be adopted are against adoption of the report, at the second of these annual general meetings there must be put to the vote a resolution that another meeting be held within 90 days at which all directors (except the managing director) who were directors at the date the remuneration report was approved at the second annual general meeting must stand for re-election. So, in summary, shareholders will be entitled to vote in favour of holding a general meeting to re-elect the Board if the Remuneration Report receives 'two strikes'. The Remuneration Report did not receive a 'first strike' at the Company's 2024 annual general meeting.

2. RESOLUTION 2: RE-ELECTION OF DONALD STEPHENS AS DIRECTOR

In accordance with rule 6.1 of the Constitution at every annual general meeting one third of the Directors for the time being or, if their number is not three or a multiple of three, then the number nearest to but not exceeding one third (excluding those who retire under rule 9.2 of the Constitution) must retire from office and are eligible for re-election. Accordingly, Mr Donald Stephens retires as a Director of the Company and, being eligible, offers himself for re-election.

A resume for Mr Stephens follows:

Donald Stephens BA(Acc), FCA

Mr Stephens is a Chartered Accountant and corporate adviser with over 25 years' experience in the accounting, mining and services industries, including 14 years as a partner of HLB Mann Judd (SA), a firm of Chartered Accountants. He is a Chartered Accountant and corporate adviser specialising in small cap ASX listed entities. Mr Stephens is the Chair of the Company's Audit and Risk Committee.

Resolution 2 is an ordinary resolution.

The Directors (with Mr Stephens abstaining) recommend that shareholders vote in favour of Resolution 2.

The chair intends to vote undirected proxies in favour of Resolution 2.

3. RESOLUTION 3: ELECTION OF ROBERT SENNITT AS DIRECTOR

Rule 9.2 of the Constitution requires that any Director appointed by the Board, either to fill a casual vacancy or as an addition to the Board, holds office only until the termination of the next annual general meeting of the Company and is eligible for re-election at that annual general meeting.

Page 7

The Board appointed Mr Robert Sennitt as an addition to the Board after the Company's last Annual General Meeting. Accordingly, Mr Sennitt retires pursuant to rule 9.2 of the Constitution and, being eligible, offers himself for re-election.

Mr Sennitt has over 25 years’ experience as an investment banker with JP Morgan, Macquarie Capital and RBC Capital Markets providing strategic advice to companies in the natural resources sector.

Mr Sennitt was appointed Managing Director and CEO of Mineral Deposits Limited (MDL) in 2015, when MDL owned 50% of the TiZir Joint Venture comprising the Grande Cote Mineral Sands Mining Operations in Senegal and the Titanium Slag and Iron Smelting operations in Norway. At MDL Mr Sennitt was responsible for the improvement and optimisation of operations, restructure and refinancing of the Joint Venture as well as driving MDL strategy where he delivered several successful outcomes including a significant recapitalisation of the company before its acquisition by Eramet SA.

Following the MDL takeover, Mr Sennitt became Senior Adviser to Appian Capital Advisory LLP (Appian) with responsibility for sourcing investments and portfolio management in the mining sector in the Australasian region.

Most recently, Mr Sennitt was Managing Director of Alicanto Minerals Limited (ASX:AQI), a mineral exploration company exploring the Bergslagen Region of Sweden.

Resolution 3 is an ordinary resolution.

The Directors (with Mr Sennitt abstaining) recommend that shareholders vote in favour of Resolution 3.

The chair intends to vote undirected proxies in favour of Resolution 3.

4. RESOLUTION 4: APPROVAL TO CHANGE COMPANY NAME

The Company proposes to change its name from Petratherm Limited to PTR Minerals Limited. The Board believes that the new name better aligns with and captures the operations and value which the Company is creating now and in the future. In particular, the Company’s focus on progressing its Muckanippie Project no longer aligns with its historical geothermal activities.

Section 157 of the Corporations Act

Section 157 of the Corporations Act requires shareholders to approve the change of name of the Company by passing a special resolution to adopt the new name. If shareholders approve the change of name, it will be effective from the date that the Australian Securities and Investments Commission updates its register to reflect the new name, which is intended to be as soon as practicable. The name ‘PTR Minerals Limited’ has been reserved by the Company.

Section 136 of the Corporations Act

For the purposes of Section 136 of the Corporations Act, approval is also being sought to amend the Constitution of the Company to replace all references to ‘Petratherm Limited’ with ‘PTR Minerals Limited’.

The Company’s ASX ticker code ‘PTR’ will not change if the name change is approved.

Page 8

Resolution 4 is a special resolution .

The Directors recommend that shareholders vote in favour of Resolution 4.

The chair intends to vote undirected proxies in favour of Resolution 4.

5. RESOLUTION 5: APPROVAL OF 10% PLACEMENT FACILITY

5.1 General

Broadly speaking, and subject to a number of exceptions, ASX Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that period.

Under ASX Listing Rule 7.1A, however, an eligible entity can seek approval from its members, by way of a special resolution passed at its annual general meeting, to increase this 15% limit by an extra 10% to 25% ( 10% Placement Facility ).

An 'eligible entity' means an entity which is not included in the S&P/ASX 300 Index and which has a market capitalisation of $300 million or less. The Company is an eligible entity for these purposes.

Resolution 5 seeks shareholder approval by way of special resolution for the Company to have the additional 10% capacity provided for in ASX Listing Rule 7.1A to issue Equity Securities without shareholder approval. The exact number of Equity Securities which may be issued under the 10% Placement Facility will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (refer to section 7.2(c)).

If Resolution 5 is passed, the Company will be able to issue Equity Securities up to the combined 25% limit in ASX Listing Rules 7.1 and 7.1A without any further shareholder approval.

If Resolution 5 is not passed, the Company will not be able to access the 10% Placement Facility and will remain subject to the 15% limit on issuing Equity Securities without shareholder approval set out in ASX Listing Rule 7.1.

5.2 Description of ASX Listing Rule 7.1A

(a) Shareholder approval

The ability to issue Equity Securities under the 10% Placement Facility is subject to shareholder approval by way of a special resolution at an annual general meeting.

(b) Equity Securities

Any Equity Securities issued under the 10% Placement Facility must be in the same class as an existing quoted class of Equity Securities of the Company.

Page 9

The Company, as at the date of the Notice, has on issue the following classes of Equity Securities:

  • ordinary shares quoted on ASX

  • options not quoted on ASX

(c) Formula for calculating 10% Placement Facility

ASX Listing Rule 7.1A.2 provides that eligible entities which have obtained shareholder approval at an annual general meeting may, during the period of the approval, issue or agree to issue, during the 10% Placement Period (refer to section 7.2(f)), a number of Equity Securities calculated in accordance with the following formula:

(A x D) – E

Where:

  • A is the number of fully paid ordinary securities on issue at the commencement of the relevant period:

  • plus the number of fully paid ordinary securities issued in the relevant period under an exception in ASX Listing Rule 7.2 other than exception 9, 16 or 17;

  • plus the number of fully paid ordinary securities issued in the relevant period on the conversion of convertible securities within ASX Listing Rule 7.2 exception 9 where:

    • the convertible securities were issued or agreed to be issued before the commencement of the relevant period; or

    • the issue of, or agreement to issue, the convertible securities was approved, or taken under the ASX Listing Rules to have been approved, under ASX Listing Rule 7.1 or ASX Listing Rule 7.4;

  • plus the number of fully paid ordinary securities issued in the relevant period under an agreement to issue securities within ASX Listing Rule 7.2 exception 16 where:

    • the agreement was entered into before the commencement of the relevant period; or

    • the agreement or issue was approved, or taken under the ASX Listing Rules to have been approved, under ASX Listing Rule 7.1 or ASX Listing Rule 7.4;

  • plus the number of any other fully paid ordinary securities issued in the relevant period with approval under ASX Listing Rule 7.1 or ASX Listing Rule 7.4;

Page 10

  • plus the number of partly paid ordinary securities that became fully paid in the relevant period;

  • less the number of fully paid ordinary securities cancelled in the relevant period.

( Note that A has the same meaning in ASX Listing Rule 7.1 when calculating an entity's 15% placement capacity. )

  • D

  • is 10%

  • E is the number of Equity Securities issued or agreed to be issued under ASX Listing Rule 7.1A.2 in the relevant period where the issue or agreement has not been subsequently approved by the holders of its ordinary securities under ASX Listing Rule 7.4.

( Note that relevant period has the same meaning in ASX Listing Rule 7.1, namely:

  • if the entity has been admitted to the official list for 12 months or more, the 12 month period immediately preceding the date of the issue or agreement; or

  • if the entity has been admitted to the official list for less than 12 months, the period from the date the entity was admitted to the official list to the date immediately preceding the date of the issue or agreement. )

(d) ASX Listing Rule 7.1 and ASX Listing Rule 7.1A

The ability of an entity to issue Equity Securities under ASX Listing Rule 7.1A is in addition to the entity's 15% placement capacity under ASX Listing Rule 7.l.

At the date of this Notice, the Company has on issue 346,641,770 quoted ordinary shares and therefore has a capacity to issue:

  • (1) 51,996,265 Equity Securities under ASX Listing Rule 7.1; and

  • (2) 34,664,177 Equity Securities under ASX Listing Rule 7.1A.

The actual number of Equity Securities that the Company will have capacity to issue under ASX Listing Rule 7.1A will be calculated at the date of issue of the Equity Securities in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (refer to section 7.2(c)).

(e)

Minimum Issue Price

The Equity Securities issued under ASX Listing Rule 7.1A.2 must be issued for a cash consideration per security which is not less than 75% of the VWAP of Equity Securities in the same class calculated over the 15 Trading Days on which trades in that class were recorded immediately before:

Page 11

  • (1) the date on which the price at which the Equity Securities are to be issued is agreed by the entity and the recipient of the Equity Securities; or

  • (2) if the Equity Securities are not issued within 10 Trading Days of the date referred to in section 7.2 (e)(1), the date on which the Equity Securities are issued.

(f) 10% Placement Period

Shareholder approval of the 10% Placement Facility under ASX Listing Rule 7.1A is valid from the date of the annual general meeting at which the approval is obtained and expires on the first to occur of:

  • (1) the date that is 12 months after the date of the annual general meeting at which the approval is obtained;

  • (2) the time and date of the entity's next annual general meeting; and

  • (3) the time and date of the approval by shareholders of a transaction under ASX Listing Rule 11.1.2 (a significant change to the nature or scale of activities) or ASX Listing Rule 11.2 (disposal of main undertaking),

( 10% Placement Period ).

5.3 ASX Listing Rule 7.1A

The effect of Resolution 5 will be to allow the Directors to issue the Equity Securities under ASX Listing Rule 7.1A during the 10% Placement Period in addition to using the Company's 15% placement capacity under ASX Listing Rule 7.1.

Resolution 5 is a special resolution and therefore requires approval of at least 75% of the votes cast by shareholders entitled to vote (in person, by proxy, by attorney or, in the case of a corporate shareholder, by a corporate representative) on the resolution.

5.4 Specific information required by ASX Listing Rule 7.3A

Pursuant to and in accordance with ASX Listing Rule 7.3A, information is provided in relation to the approval of the 10% Placement Facility as follows to the extent that such information is not disclosed elsewhere in this Explanatory Memorandum:

  • (a) The Company may seek to issue the Equity Securities for cash consideration. In such circumstances, the Company intends to use the funds raised towards an acquisition of new assets or investments (including expense associated with such acquisition) and/or general working capital.

  • (b) There is a risk that:

  • (1) the market price for the Company's Equity Securities in the same class may be significantly lower on the date of the issue of the Equity Securities than on the date of the Meeting; and

Page 12

  • (2) the Equity Securities may be issued at a price that is at a discount to the market price for the Company's Equity Securities in the same class on the issue date,

which may have an effect on the amount of funds raised by the issue of the Equity Securities.

The table below shows the risk of voting dilution of existing shareholders on the basis of the current market price of shares and the current number of ordinary shares for variable 'A' calculated in accordance with the formula in ASX Listing Rule 7.1A.2 as at the date of this Notice.

The table also shows:

  • (i) two examples where variable 'A' has increased, by 50% and 100%. Variable 'A' is based on the number of ordinary shares the Company has on issue. The number of ordinary shares on issue may increase as a result of issues of ordinary shares that do not require shareholder approval (for example, a pro rata entitlements issue) or future specific placements under ASX Listing Rule 7.1 that are approved at a future shareholders' meeting; and

  • (ii) two examples of where the issue price of ordinary shares has decreased by 50% and increased by 100% as against the current market price.

Variable 'A' in formula in
ASX Listing Rule 7.1A.2
Issue Price
$0.155
50% decrease in
issue price
$0.31
issue price
$0.62
100% increase in
issue price
Current Variable 'A'
346,641,770 shares
10% voting
dilution
34,664,177 shares 34,664,177 shares 34,664,177 shares
Funds raised $5,372,947 $10,745,895 $21,491,790
50% increase in current
Variable 'A'
455,223,456 shares
10% voting
dilution
51,996,265 shares 51,996,265 shares 51,996,265 shares
Funds raised $8,059,421 $16,118,842 $32,237,684
100% increase in current
Variable 'A'
606,964,608 shares
10% voting
dilution
69,328,354 shares 69,328,354 shares 69,328,354 shares
Funds raised $10,745,895 $21,491,790 $42,983,579

Page 13

The table has been prepared on the following assumptions:

  • The Company issues the maximum number of Equity Securities available under the 10% Placement Facility.

  • No current options are exercised into shares before the date of the issue of the Equity Securities.

  • The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital at the time of issue. This is why the voting dilution is shown in each example as 10%.

  • The table does not show an example of dilution that may be caused to a particular shareholder by reason of placements pursuant to the 10% Placement Facility, based on that shareholder's holding at the date of the Meeting.

  • The table shows only the effect of issues of Equity Securities under ASX Listing Rule 7.1A and no other issues of Equity Securities.

  • The issue of Equity Securities under the 10% Placement Facility consists only of shares.

  • The issue price is $0.31, being the closing price of the shares on ASX on 18 September 2025.

  • (c) The Company's allocation policy is dependent on the prevailing market conditions at the time of any proposed issue pursuant to the 10% Placement Facility. The identity of the allottees of Equity Securities and the number of Equity Securities allotted to each will be determined on a case-by-case basis having regard to factors including, but not limited to, the following:

  • (1) the methods of raising funds that are available to the Company including, but not limited to, rights issue or other issue in which the existing security holders can participate;

  • (2) the effect of the issue of the Equity Securities on the control of the Company;

  • (3) the financial situation and solvency of the Company; and

  • (4) advice from corporate, financial and broking advisers (if applicable).

The allottees under the 10% Placement Facility have not been determined as at the date of this Notice but may include existing substantial shareholders (subject to shareholder approval, if required) and/or new shareholders who are not related parties or associates of a related party of the Company.

  • (d) The Company previously obtained shareholder approval under ASX Listing Rule 7.1A at its 2024 annual general meeting.

  • (1) The Company not issued any Equity Securities under ASX Listing Rule 7.1A.2 in the 12 months preceding the date of this Meeting

Page 14

(e) At the time of dispatching this Notice, the Company is not proposing to make an issue of Equity Securities under ASX Listing Rule 7.1A.2.

Resolution 5 is a special resolution .

The Directors recommend that shareholders vote in favour of Resolution 5.

The chair intends to vote undirected proxies in favour of Resolution 5.

6. RESOLUTION 6: INCREASE IN TOTAL AGGREGATE REMUNERATION FOR NON-EXECUTIVE DIRECTORS

6.1 General

Resolution 6 seeks Shareholder approval for the purposes of clause 43.1 of the Constitution and Listing Rule 10.17 to increase the total aggregate amount of fees payable to non-executive Directors from $300,000 to $500,000.

Listing Rule 10.17 provides that an entity must not increase the total aggregate amount of directors’ fees payable to all of its non-executive directors without the approval of holders of its ordinary securities.

Directors’ fees include all fees payable by the entity or any of its child entities to a non-executive director for acting as a director of the entity or any of its child entities (including attending and participating in any board committee meetings), superannuation contributions for the benefit of a non-executive director and any fees which a non-executive director agrees to sacrifice for other benefits. It does not include reimbursement of genuine out of pocket expenses, genuine “special exertion” fees paid in accordance with an entity’s constitution, or securities issued to a nonexecutive director under Listing Rules 10.11 or 10.14 with the approval of the holders of its ordinary securities.

Clause 43.1 and 43.3 of the Constitution provides that the Company must not increase the total amount of directors’ remuneration payable by it without the members’ approval by ordinary resolution at a general meeting, excluding the salary of an Executive Officer or Managing Director.

Resolution 6 seeks to increase the maximum aggregate amount of fees payable to the non-executive Directors by an amount of $200,000 to $500,000.

This amount has been determined after a review of the current maximum aggregate, which has not been increased since the Company listed in 2004, and the Directors believe that this level of remuneration is in line with corporate remuneration of similar companies.

Whilst it is not envisaged that the maximum amount sought will be utilised immediately, the increase to maximum aggregate amount of fees payable may enable the Company to:

(a) fairly remunerate both existing and any new non-executive directors joining the Board;

Page 15

(b) remunerate its non-executive Directors appropriately for the expectations placed upon them both by the Company and the regulatory environment in which it operates; and

(c) have the ability to attract and retain non-executive directors whose skills and qualifications are appropriate for a company of the size and nature of the Company.

If Resolution 6 is passed, the maximum aggregate amount of fees payable to the nonexecutive Directors will increase by $200,000 to $500,000.

If Resolution 6 is not passed, the maximum aggregate amount of fees payable to nonexecutive Directors will remain at $300,000. This may inhibit the ability of the Company to remunerate, attract and retain appropriately skilled non-executive Directors.

A voting exclusion statement applies to Resolution 6.

6.2 Securities issued to non-executive Directors

As required by Listing Rule 10.17 The securities issued to non-executive Directors in the preceding three years pursuant to Listing Rules 10.11 and 10.14 are set out below.

Ordinary shares issued to Directors pursuant to Listing Rule 10.11 on 29 November 2024, pursuant to shareholder approval at 2024 Annual General Meeting:

Director Shares issued Price per
Share
Funds received by
the Company
Derek Carter 1,428,572 $0.035 $50,000
Simon O'Loughlin 1,428,571 $0.035 $50,000
Donald Stephens 1,428,571 $0.035 $50,000
Simon Taylor 1,428,571 $0.035 $50,000
5,714,285 $200,000

Zero Exercise Price Options (ZEPOs) issued to Directors pursuant to Listing Rule 10.14 on 15 May 2025, pursuant to shareholder approval at 20 March 2025 Extraordinary General Meeting:

Director No. of ZEPOs issued Vesting Date Expiry Date
Mr Derek Carter 250,000 (Tranche 1)
250,000 (Tranche 2)
250,000 (Tranche 3)
31/12/2025
31/12/2026
31/12/2027
31/12/2027
31/12/2028
31/12/2029

Page 16

Mr Donald Stephens 200,000 (Tranche 1) 31/12/2025 31/12/2027
200,000 (Tranche 2) 31/12/2026 31/12/2028
200,000 (Tranche 3) 31/12/2027 31/12/2029
Mr Simon O'Loughlin 200,000 (Tranche 1) 31/12/2025 31/12/2027
200,000 (Tranche 2) 31/12/2026 31/12/2028
200,000 (Tranche 3) 31/12/2027 31/12/2029
Mr Simon Taylor 200,000 (Tranche 1) 31/12/2025 31/12/2027
200,000 (Tranche 2) 31/12/2026 31/12/2028
200,000 (Tranche 3) 31/12/2027 31/12/2029

Ordinary shares issued to Directors pursuant to Listing Rule 10.11 on 26 June 2025, pursuant to shareholder approval at 12 June 2025 Extraordinary General Meeting:

Director Shares issued Price per
Share
Funds received by
the Company
Derek Carter 250,000 $0.22 $55,000
Simon O'Loughlin 250,000 $0.22 $55,000
Donald Stephens 250,000 $0.22 $55,000
Simon Taylor 250,000 $0.22 $55,000
1,000,000 $220,000

Resolution 6 is an ordinary resolution .

The Directors have an interest in the outcome of Resolution 6 and therefore do not make a recommendation on how shareholders ought to vote on the Resolution.

The chair intends to vote all undirected proxies in favour of Resolution 6.

Page 17

7. GLOSSARY

In this Explanatory Memorandum and Notice of Annual General Meeting the following expressions have the following meanings unless stated otherwise or unless the context otherwise requires:

10% Placement Facility has the meaning given in section 7.1;

10% Placement Period has the meaning given in section 7.2(f);

ASX means ASX Limited ACN 008 624 691;

ASX Listing Rules means the listing rules of ASX;

Board means the board of directors of the Company;

Closely Related Party of a member of the Key Management Personnel for an entity means:

  • (a) a spouse or child of the member;

  • (b) a child of the member's spouse;

  • (c) a dependant of the member or of the member's spouse;

  • (d) anyone else who is one of the member's family and may be expected to influence the member, or be influenced by the member, in the member's dealings with the entity;

  • (e) a company the member controls; or

  • (f) a person prescribed as such by the Corporations Regulations 2001 (Cth);

Company means Petratherm Limited ACN 106 806 884;

Constitution means the existing constitution of the Company;

Corporations Act means Corporations Act 2001 (Cth);

Director means a director of the Company;

Equity Securities has the same meaning as in the ASX Listing Rules;

Key Management Personnel has the same meaning as in the accounting standards as defined in section 9 of the Corporations Act (so the term broadly includes those persons having authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly, including any director, whether executive or otherwise, of the Company);

Meeting means the meeting of shareholders convened by the Notice;

Notice means the notice of annual general meeting to which this Explanatory Memorandum is attached;

Page 18

Trading Day means a day determined by ASX to be a trading day in accordance with the ASX Listing Rules; and

VWAP means volume weighted average market price.

Page 19

==> picture [73 x 77] intentionally omitted <==

Need assistance?

Phone:

1300 850 505 (within Australia) +61 3 9415 4000 (outside Australia)

Online:

www.investorcentre.com/contact

YOUR VOTE IS IMPORTANT

For your proxy appointment to be effective it must be received by 11:30am (ACDT) on Tuesday, 4 November 2025.

Proxy Form

How to Vote on Items of Business

Lodge your Proxy Form:

All your securities will be voted in accordance with your directions.

Online:

APPOINTMENT OF PROXY

Voting 100% of your holding: Direct your proxy how to vote by marking one of the boxes opposite each item of business. If you do not mark a box your proxy may vote or abstain as they choose (to the extent permitted by law). If you mark more than one box on an item your vote will be invalid on that item.

Voting a portion of your holding: Indicate a portion of your voting rights by inserting the percentage or number of securities you wish to vote in the For, Against or Abstain box or boxes. The sum of the votes cast must not exceed your voting entitlement or 100%.

Appointing a second proxy: You are entitled to appoint up to two proxies to attend the meeting and vote on a poll. If you appoint two proxies you must specify the percentage of votes or number of securities for each proxy, otherwise each proxy may exercise half of the votes. When appointing a second proxy write both names and the percentage of votes or number of securities for each in Step 1 overleaf.

Lodge your vote online at

www.investorvote.com.au using your secure access information or use your mobile device to scan the personalised QR code.

Your secure access information is

Control Number: 188122 SRN/HIN:

For Intermediary Online subscribers (custodians) go to www.intermediaryonline.com

A proxy need not be a securityholder of the Company.

SIGNING INSTRUCTIONS FOR POSTAL FORMS

Individual: Where the holding is in one name, the securityholder must sign.

Joint Holding: Where the holding is in more than one name, all of the securityholders should sign.

Power of Attorney: If you have not already lodged the Power of Attorney with the registry, please attach a certified photocopy of the Power of Attorney to this form when you return it.

Companies: Where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can also sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please sign in the appropriate place to indicate the office held. Delete titles as applicable.

By Mail:

Computershare Investor Services Pty Limited GPO Box 242 Melbourne VIC 3001 Australia

By Fax:

1800 783 447 within Australia or +61 3 9473 2555 outside Australia

PARTICIPATING IN THE MEETING

Corporate Representative

If a representative of a corporate securityholder or proxy is to participate in the meeting you will need to provide the appropriate “Appointment of Corporate Representative”. A form may be obtained from Computershare or online at www.investorcentre.com/au and select "Printable Forms".

PLEASE NOTE: For security reasons it is important that you keep your SRN/HIN confidential.

You may elect to receive meeting-related documents, or request a particular one, in electronic or physical form and may elect not to receive annual reports. To do so, contact Computershare.

320862_0_COSMOS_Sample_Proxy/000001/000001/i

Change of address. If incorrect, mark this box and make the correction in the space to the left. Securityholders sponsored by a broker (reference number commences with ‘ X ’) should advise your broker of any changes.

Proxy Form

Please mark to indicate your directions

Step 1 Appoint a Proxy to Vote on Your Behalf

I/We being a member/s of Petratherm Ltd hereby appoint

the Chairman OR of the Meeting

PLEASE NOTE: Leave this box blank if you have selected the Chairman of the Meeting. Do not insert your own name(s).

or failing the individual or body corporate named, or if no individual or body corporate is named, the Chairman of the Meeting, as my/our proxy to act generally at the meeting on my/our behalf and to vote in accordance with the following directions (or if no directions have been given, and to the extent permitted by law, as the proxy sees fit) at the Annual General Meeting of Petratherm Ltd to be held at HLB Mann Judd, Level 1, 169 Fullarton Road, Dulwich, SA 5065 on Thursday, 6 November 2025 at 11:30am (ACDT) and at any adjournment or postponement of that meeting. Chairman authorised to exercise undirected proxies on remuneration related resolutions: Where I/we have appointed the Chairman of the Meeting as my/our proxy (or the Chairman becomes my/our proxy by default), I/we expressly authorise the Chairman to exercise my/our proxy on Resolutions 1 and 6 (except where I/we have indicated a different voting intention in step 2) even though Resolutions 1 and 6 are connected directly or indirectly with the remuneration of a member of key management personnel, which includes the Chairman. Important Note: If the Chairman of the Meeting is (or becomes) your proxy you can direct the Chairman to vote for or against or abstain from voting on Resolutions 1 and 6 by marking the appropriate box in step 2.

Step 2
Items of Business
PLEASE NOTE:If you mark theAbstainbox for an item, you are directing your proxy not to vote on your
behalf on a show of hands or a poll and your votes will not be counted in computing the required majority.
For
Against Abstain
Resolution 1
Adoption of Remuneration Report
Resolution 2
Re-election of Donald Stephens as Director
Resolution 3
Election of Robert Sennitt as Director
Resolution 4
Approval to Change Company Name
Resolution 5
Approval of 10% Placement Facility
Resolution 6
Increase in total aggregate remuneration for Non-Executive Directors

For Against Abstain

The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business. In exceptional circumstances, the Chairman of the Meeting may change his/her voting intention on any resolution, in which case an ASX announcement will be made.

Step 3 Signature of Securityholder(s) This section must be completed.

Individual or Securityholder 1
Securityholder 2
Securityholder 3
Sole Director & Sole Company Secretary
Director
Director/Company Secretary
Update your communication details
By providing your email address, you consent to receive future Notice
of Meeting & Proxy communications electronically
Mobile Number
Email Address
(Optional)
Date
/ /
/ /

PTR